These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6382892)

  • 1. Duration of residual B-cell function in maturity-onset diabetes.
    Cignarelli M; Cospite MR; Stefanelli G; Guastamacchia E; Nardelli G; Giorgino R
    Acta Diabetol Lat; 1984; 21(2):161-6. PubMed ID: 6382892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E; Coscelli C; Butturini U
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
    Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
    Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of C-peptide secretion in noninsulin-dependent diabetic patients with long duration of insulin treatment.
    Hsieh SD; Akanuma Y; Kawazu S; Mashiko S; Kanazawa Y; Iwamoto Y; Kikuchi M; Kosaka K
    Endocrinol Jpn; 1983 Jun; 30(3):373-80. PubMed ID: 6363048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function.
    Madsbad S; Faber OK; Binder C; Alberti KG; Lloyd B
    Acta Diabetol Lat; 1981; 18(2):115-21. PubMed ID: 7018146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma C-peptide levels in health and impaired glucose tolerance: relations to blood glucose and relative body weight.
    Birgerstam G; Malmquist J
    Scand J Clin Lab Invest; 1985 Dec; 45(8):707-12. PubMed ID: 3909371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
    Hendriksen C; Faber OK; Drejer J; Binder C
    Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is type 2 diabetes a different disease in obese and nonobese patients?
    Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P
    Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
    Hsieh SD; Kanazawa Y; Akanuma Y
    Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual beta-cell function in type II diabetes and evaluation of the hepatic insulin extraction.
    Toledo e Souza IT; Wajchenberg BL; Prestes Cesar F; Almeida Neto JS
    Horm Metab Res; 1983 Dec; 15(12):575-80. PubMed ID: 6363239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing beta-cell function and insulin sensitivity in patients with type 2 (non-insulin-dependent) diabetes.
    Groop L; Tolppanen EM
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):505-10. PubMed ID: 6382897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.
    Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I
    Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
    Kudolo GB
    J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes.
    Glaser B; Leibovich G; Nesher R; Hartling S; Binder C; Cerasi E
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):365-73. PubMed ID: 3293339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.